Innovation ID | 552 |
Version ID | 422 |
Innovation Title | Groundnut inbred variety CG17 for cultivation in low to mid-altitudes in Malawi and Zambia |
Innovation description | CG17 is an early-maturing Spanish variety that is high-yielding (1.3 to 1.8 mt/ha). This variety demonstrates biotic stress resistance, and produces grain with high protein and digestibility. This variety has been tested in Malawi and Zambia under the AVISA Project, and will potentially contribute to SDG Goals 1 and 2. |
Reporting Staff | James Mwololo (ICRISAT) |
Year (Reporting) | 2020 |
Reporting status | Approved |
Innovation Type | Genetic (variety and breeds) |
Number of varieties | 1 |
Stage of Innovation | Stage 3: available/ ready for uptake |
Year (Stage) | 2020 |
Stage Description | CG17 was released on December 17, 2020 for cultivation in low to mid-altitudes Malawi and Zambia. Efforts for promotion and wide cultivation are underway. This variety is positioned to replace an old existing variety JL24. |
Has a lead organization | yes |
Lead Organization | Ministry of Agriculture Irrigation and Water Development, Department of Agricultural Research Services |
Top 5 contributors | International Crops Research Institute for the Semi-Arid Tropics |
All partners | |
Main CRP | CGIAR Research Program on Grain Legumes and Dryland Cereals |
Flagship project | FP4-Variety and Hybrid Development |
Cluster | FP4-3-Product testing and release |
Other CRPs-Flagships-Clusters |
Geographic scope | National |
Regions | |
Countries | Malawi,Zambia |
Main Sub-IDO | Enhanced genetic gain |
Other Sub-IDO | Closed yield gaps through improved agronomic and animal husbandry practices |
Other Sub-IDO | Reduced production risk |
Evidences | List of crop varieties and hybrids released in 2020 co-developed by ICRISAT and CRP-GLDC with partners [https://mel.cgiar.org/uploads/relatedfiles/jhF3fH3GLzIx9UvsOqbzlMPwA0MDgf.xlsx] |
Milestones | 6814-172-37920 - New suite of resilient varieties released by NARS partners. (Phase 1 investments start being released) |
Outcome Impact Case |
Policy |